Teva Pharmaceutical Industries | TEVA - Ebitda

Aktienkurs
9,270.00
Täglich Wechseln
71.00 0.77%
Monatlich
-0.18%
Jährlich
71.70%
Q2 Prognose
8,997.46




Ebitda Veränderung Datum
Aspen Pharmacare ZAR 6.06B 867M 2024-06
Cipla INR 12.55B 6.4B 2025-12
Dr.Reddys Laboratories INR 20.89B 117M 2025-12
Guangzhou Baiy CNY 961.82M 1.37B 2025-06
Jiangsu Hengrui CNY 2.3B 678.46M 2025-12
Kalbe Farma IDR 1.3T 18.7B 2025-06
Richter Gedeon HUF 84.16B 8.44B 2024-12
Sh Fosun Pharma CNY 1.69B 17.13M 2025-06
Sun Pharmaceuticals INR 49.48B 8.52B 2025-12
Teva Pharmaceutical Industries USD 1.64B 243M 2025-12